The utility of N-terminal proBNP ( NT-proBNP ) to predict the occurrence of death and hospitalization was prospectively evaluated in the COPERNICUS study , which enrolled patients with an ejection fraction < 25 % and symptoms of chronic congestive heart failure at rest or on minimal exertion .
